• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
+49 (0) 69 / 606 278 – 0
[email protected]
Contact form
Patent- & Rechtsanwaltskanzlei

Patent- & Rechtsanwaltskanzlei

  • Deutsch

+49 (0) 69 / 606 278 – 0

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • xing
  • Email
MENUMENU
  • Services
    • Advice On Protective IP Rights
    • Patent Application /TM Registration
    • Enforcement Of IP Rights
    • Defence Against IP Rights Enforcement
    • Costs
  • Company
    • Fields of Law
      • Patent Law
      • Utility Model Law
      • Employees’ Inventions
      • Trademark Law
      • Design Law
      • Trademark and Product Piracy
      • Expert Opinions
    • Our Law Firm
      • Dr. Karl-Hermann Meyer-Dulheuer
      • Dr. Tim Meyer-Dulheuer
      • Dr. Klaus Zimmermann
      • Zhichao Ying
      • Clara Elinor Grünewald
    • Commitment
  • Contact
    • Where To Find Us
    • Write us!
    • Request call back
  • Blog

The Top 10 Pharma Brands 2016

10. April 2016

A global study released by InterbrandHealth identifies the biopharma companies that are addressing healthcare professionals’ (HCPs), payers’, and policymakers’ needs. A commitment to brand is a promise to address healthcare challenges and meet the needs of these healthcare professionals.

Pills

The study examines what value means to HCPs and illustrates the influence the corporate brand has in conveying that value. It reveals how leading companies are beginning to deliver on what matters to HCPs.

Looking to the future, healthcare professionals desire a commitment to innovative healthcare solutions that go “beyond the pill.”

As a result, leading biopharma companies are adapting their business models, increasing transparency, exploring nontraditional solutions in areas like digital therapies, and ramping up their corporate citizenship activities.

“Biopharma is at a pivotal moment, and the time for change is now,” said Jane Parker, InterbrandHealth’s CEO.

Dr. Ronnie Hershman, a cardiologist affiliated with NYU Langone Long Island Cardiac Care and the CEO of HealthEffect, LLC, noted, “The biopharma industry has relied on blockbuster drugs for a long time, but healthcare is changing, and what physicians need has changed. Biopharma companies need to shift and think about what else they can offer.”

Best Pharma Brands ranks these leading companies by qualifying the industry’s definition of value through brand, then quantifying the corporate brand’s contribution to business performance. The ranking identifies the 10 most valuable biopharma brands. In total, these 10 brands represent approximately USD $129 billion in brand value. Pfizer and the Roche Group secure the #1 and #2 positions on the ranking.

Best Pharma Brands Ranking

Graphic_Top-Pharma-Brands-2016

Best Pharma Brands also sets an important industry benchmark by highlighting the need for biopharma companies to change how they interact with the market and meet the needs of the healthcare community.

Parker commented that “these 10 biopharma brands are embracing a strategy that is somewhat new to the health and life sciences sector: they are effectively leveraging their corporate brands and, in doing so, they are growing their businesses, fueling innovation, and developing meaningful solutions for patients on a global scale.”

Best Pharma Brands is powered by global research data, feedback from HCPs, and data-driven insights. The underlying methodology mirrors Interbrand’s Best Global Brands, which demonstrates that strong brands can withstand market volatility and are more likely to outperform key financial indices like the S&P 500.

To be considered, biopharma brands must have a global presence, generate revenue from the sale of prescription medicines, report the ratio of revenues generated from sales of prescription medicines, possess a strong pipeline of potential future prescription medicines, have awareness among HCPs, and serve as the primary external-facing manufacturer brand.

 

Source:
InterbrandHealth Press Release

  • share  
  • share 
  • share 
  • tweet  
  • share 

Category iconTrademark Law Tag icon2016,  Merck,  Novartis,  Roche

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

More articles about: Trademark Law

All articles

Blog Menu

  • Design Law
  • Healthcare & Lifesciences
  • International Intellectual Property
  • Licenses
  • News from our law firm
  • Overall
  • Patent Law
  • Product- and Trademark piracy
  • Trademark Law
This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Recent Posts

  • Own trademark application fails – despite comparable trademarks: Equal treatment? 5. March 2021
  • Intel to pay 2.2 billion in damages – to VLSI / Fortress Investment 5. March 2021
  • BGH “FRAND II” – SEP Licensing as Distributor? 2. March 2021
  • Suspension of infringement proceedings 1. March 2021

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Das könnte Sie auch interessieren:

5. March 2021
Own trademark application fails – despite comparable trademarks: Equal treatment?

Own trademark application fails – despite comparable trademarks: Equal treatment?

1. March 2021
Suspension of infringement proceedings

Suspension of infringement proceedings

16. February 2021
BGH: Black Forest ham – not only packaged in the Black Forest

BGH: Black Forest ham – not only packaged in the Black Forest

16. February 2021
UK trademark after Brexit: earlier UK trademark in opposition

UK trademark after Brexit: earlier UK trademark in opposition

11. February 2021
EU figurative marks: Panthé figurative mark – a panther mark?

EU figurative marks: Panthé figurative mark – a panther mark?

9. February 2021
BGH ruling: Classe E versus German E-Klasse

BGH ruling: Classe E versus German E-Klasse

Footer

Contact

Franklinstr. 61-63
D-60486 Frankfurt am Main
Germany

+49 (0) 69 / 606 278 – 0
+49 (0) 69 / 606 278 – 199
[email protected]

Customer Reviews

Meyer-Dulheuer MD Legal Patentanwälte PartG mbB Patentrecht, Markenrecht, Eigentum hat 4,78 von 5 Sternen 23 Bewertungen auf ProvenExpert.com

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Law Firm

  • Request non-binding call back
  • Info secure emails
  • Company
  • Our Law Firm
  • ISO Certificate
  • Privacy Policy
  • Data handling for clients
  • Imprint

Follow Us

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • xing
  • Email

Newsletter Signup

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

© Patent- & Rechtsanwaltskanzlei Meyer-Dulheuer MD Legal Patentanwälte PartG mbB

Kontaktformular

 

Rufen Sie uns an, schicken Sie uns eine Mail oder füllen Sie das Kontaktformular aus.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Contact Form

 

Give us a call, send us an email or fill out the contact form.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form